Details for Patent: 7,807,135
Which drugs does patent 7,807,135 protect, and when does it expire?
Patent 7,807,135 protects NEURACEQ and is included in one NDA.
This patent has thirty-five patent family members in twenty-seven countries.
Summary for Patent: 7,807,135
| Title: | Stilbene derivatives and their use for binding and imaging amyloid plaques |
| Abstract: | This invention relates to a method of imaging amyloid deposits and to labeled compounds, and methods of making labeled compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits. |
| Inventor(s): | Hank F. Kung, Mei-Ping Kung, Zhi-Ping Zhuang |
| Assignee: | University of Pennsylvania Penn |
| Application Number: | US11/305,333 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,807,135 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 7,807,135
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lantheus | NEURACEQ | florbetaben f-18 | SOLUTION;INTRAVENOUS | 204677-001 | Mar 19, 2014 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | NEURACEQ IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF THE BRAIN TO ESTIMATE P-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT PATIENTS WITH COGNITIVE IMPAIRMENT | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,807,135
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2213652 | ⤷ Start Trial | C300719 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2213652 | ⤷ Start Trial | CA 2015 00018 | Denmark | ⤷ Start Trial |
| European Patent Office | 2213652 | ⤷ Start Trial | C20150010 00142 | Estonia | ⤷ Start Trial |
| European Patent Office | 2213652 | ⤷ Start Trial | PA2015005 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
